The influence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma
To evaluate the influence of mitomycin C (MMC) concentration on the outcome of trabeculectomy in uveitic glaucoma.
Retrospective comparative study included 50 patients who underwent MMC-enhanced trabeculectomy for uncontrolled uveitic glaucoma. Patients were divided into two groups based on the concentration of MMC used during trabeculectomy (high [0.04%] or low [0.02%]). The main outcome measures were: the intraocular pressure (IOP), the number of antiglaucoma medications, the need for further glaucoma surgeries, and trabeculectomy success.
There were no differences in the IOP nor antiglaucoma medications. The success rates were 76.0 and 68.0%, while the failure rates were 24.0 and 32.0% in the 0.02 and 0.04% MMC groups, respectively.
Trabeculectomy augmented with low (0.02%) MMC concentration seems to have comparable outcomes in uveitic glaucoma compared with high (0.04%) concentration.
KeywordsGlaucoma Mitomycin C Outcome Trabeculectomy Uveitis
This work was supported by College of Medicine Research Center. Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 22.Ozkiris A, Tamcelik N (2005) Long-term results of trabeculectomy with different concentrations of mitomycin C in refractory developmental glaucoma. J Ped Ophthalmol Strabismus 42(2):97–102Google Scholar